Jun 2026 (Q2 FY26) — Aug 12, 2026
Similarweb Q2 FY26 — Record ARR, Profitability, and AI-Driven Enterprise Growth
Read the full callSimilarweb (SMWB) earnings
- Jun 2026 (Q2 FY26)
- Dec 2025
Similarweb earnings: last reported Wed, 12 Aug 2026, for the quarter ended Jun 2026.
Price
$8.79 +5.90% · +$0.49
Performance +0.7% 1Y
1Y: $8.73 on 14 Oct 2025 → $8.79. High $9.29 (31 Aug 2026), low $2.33 (10 Apr 2026).
- Previous close
- $8.3
- 52-week range
- $2.33 – $9.29
- One year
- −0.90%
Overview
- Symbol
- SMWB
- Sector
- Information Technology
- Industry
- Services-Computer Programming, Data Processing, Etc.
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Similarweb earnings calls (SMWB)
Financials
What the filings say
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Equity capital | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | — | -171 | -240 | -324 | -353 | -365 | -397 |
| Total liabilities | — | 113 | 142 | 224 | 223 | 215 | 238 |
| Fixed assets | — | 6 | 6 | 32 | 29 | 26 | 22 |
| Investments | — | 30 | 0 | — | — | — | — |
| Total assets | — | 104 | 227 | 246 | 239 | 243 | 261 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -10 | -4 | -28 | -46 | -3 | 30 | 15 |
| Cash from investing | 0 | -31 | 7 | -33 | -3 | -19 | -13 |
| Cash from financing | 10 | 51 | 125 | 29 | 1 | -19 | 7 |
| Net cash flow | 1 | 17 | 105 | -51 | -6 | -8 | 9 |
| Capital expenditure | -0 | -1 | -2 | -28 | -2 | -1 | -1 |
| Free cash flow | -10 | -5 | -30 | -74 | -5 | 29 | 13 |
Insider filings
39 filings between May 18, 2026 and Sep 24, 2026.
Open market
decisions to buy or sellPurchases
$1.02M
7 purchases by 4 insiders
Sales
$15.17M
24 sales by 1 insider
58% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 8
- Option exercise — converted options into shares
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Offer Or | $407.1K | $15.17M | Sep 24, 2026 |
| Beit-On Harel Moshe | $291.8K | — | May 20, 2026 |
| Eilam Barak | $193.0K | — | May 21, 2026 |
| Rapaport-Dagim Tamar | $128.9K | — | May 18, 2026 |
Latest filings (39)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 24, 2026 | Offer Or Chief Executive Officer | Sale 10b5-1 plan | 113,900 | $875.8K |
| Sep 24, 2026 | Offer Or Chief Executive Officer | Sale 10b5-1 plan | 400 | $3.3K |
| Sep 23, 2026 | Offer Or Chief Executive Officer | Sale 10b5-1 plan | 28,400 | $242.4K |
| Sep 22, 2026 | Offer Or Chief Executive Officer | Sale 10b5-1 plan | 34,500 | $289.0K |
| Sep 21, 2026 | Offer Or Chief Executive Officer | Sale 10b5-1 plan | 32,200 | $270.6K |
| Sep 18, 2026 | Offer Or Chief Executive Officer | Sale 10b5-1 plan | 37,500 | $309.3K |
| Sep 17, 2026 | Offer Or Chief Executive Officer | Sale 10b5-1 plan | 30,400 | $253.7K |
| Sep 16, 2026 | Offer Or Chief Executive Officer | Sale 10b5-1 plan | 45,719 | $383.9K |
| Sep 15, 2026 | Offer Or Chief Executive Officer | Sale 10b5-1 plan | 26,691 | $227.6K |
| Sep 14, 2026 | Offer Or Chief Executive Officer | Sale 10b5-1 plan | 52,900 | $451.6K |
| Sep 11, 2026 | Offer Or Chief Executive Officer | Sale 10b5-1 plan | 59,000 | $474.9K |
| Sep 10, 2026 | Offer Or Chief Executive Officer | Sale 10b5-1 plan | 59,200 | $477.3K |
| Sep 9, 2026 | Offer Or Chief Executive Officer | Sale 10b5-1 plan | 86,300 | $695.3K |
| Sep 8, 2026 | Offer Or Chief Executive Officer | Sale 10b5-1 plan | 60,700 | $505.6K |
| Aug 26, 2026 | Offer Or Chief Executive Officer | Option exercise | 39,302 | $106.5K |
| Aug 26, 2026 | Offer Or Chief Executive Officer | Option exercise | 164,817 | $446.7K |
| Aug 26, 2026 | Offer Or Chief Executive Officer | Sale | 164,817 | $1.48M |
| Aug 26, 2026 | Offer Or Chief Executive Officer | Sale | 39,302 | $354.2K |
| Aug 26, 2026 | Offer Or Chief Executive Officer | Option exercise | 39,000 | $15.6K |
| Aug 26, 2026 | Offer Or Chief Executive Officer | Sale | 39,000 | $351.2K |
| Aug 26, 2026 | Offer Or Chief Executive Officer | Option exercise | 140,008 | $425.6K |
| Aug 26, 2026 | Offer Or Chief Executive Officer | Sale | 140,008 | $1.26M |
| Aug 14, 2026 | Offer Or Chief Executive Officer | Sale | 59,992 | $534.0K |
| Aug 14, 2026 | Offer Or Chief Executive Officer | Option exercise | 75,000 | $30.0K |
| Aug 14, 2026 | Offer Or Chief Executive Officer | Sale | 75,000 | $663.9K |
| Aug 14, 2026 | Offer Or Chief Executive Officer | Option exercise | 59,992 | $182.4K |
| Aug 13, 2026 | Offer Or Chief Executive Officer | Sale | 106,105 | $928.4K |
| Aug 13, 2026 | Offer Or Chief Executive Officer | Option exercise | 200,000 | $80.0K |
| Aug 13, 2026 | Offer Or Chief Executive Officer | Sale | 228,500 | $2.02M |
| Aug 13, 2026 | Offer Or Chief Executive Officer | Option exercise | 228,500 | $694.6K |
| Aug 13, 2026 | Offer Or Chief Executive Officer | Sale | 40,000 | $356.0K |
| Aug 13, 2026 | Offer Or Chief Executive Officer | Sale | 200,000 | $1.76M |
| Jun 1, 2026 | Offer Or Chief Executive Officer | Purchase | 50,000 | $207.5K |
| May 21, 2026 | Eilam Barak Director | Purchase | 50,000 | $193.0K |
| May 20, 2026 | Beit-On Harel Moshe Director | Purchase | 75,000 | $291.8K |
| May 19, 2026 | Offer Or Chief Executive Officer | Purchase | 50,000 | $179.0K |
| May 19, 2026 | Offer Or Chief Executive Officer | Purchase | 3,000 | $10.7K |
| May 18, 2026 | Offer Or Chief Executive Officer | Purchase | 3,105 | $9.9K |
| May 18, 2026 | Rapaport-Dagim Tamar Director | Purchase | 40,000 | $128.9K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for SIMILARWEB LTD.
Free account. Everything above stays public.
Write why you follow SIMILARWEB LTD. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading